Header Logo

Connection

Raid Aljumaily to Matrix Metalloproteinase Inhibitors

Back to Details
This is a "connection" page, showing publications Raid Aljumaily has written about Matrix Metalloproteinase Inhibitors.
Raid Aljumaily
Connection Strength
0.108
Matrix Metalloproteinase Inhibitors
  1. Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer. Cancer Res. 2013 Apr 15; 73(8):2457-2467.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.